The Short Answer
Ozempic and Wegovy both contain semaglutide, but Ozempic is FDA-approved for type 2 diabetes (up to 2.0 mg) while Wegovy is approved for weight loss (up to 2.4 mg). The key difference isn't the drug — it's the dose, indication, and insurance coverage.
Side-by-Side Comparison
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| Drug Class | GLP-1 Receptor Agonist | GLP-1 Receptor Agonist |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| FDA Approval | Type 2 Diabetes | Chronic Weight Management |
| Max Dose | 2.0 mg weekly | 2.4 mg weekly |
| Administration | Weekly injection | Weekly injection |
| Avg Weight Loss | ~10-14% (off-label) | ~15% (on-label) |
| Insurance Coverage | Often covered for diabetes | Often limited for weight loss |
Key Differences
- The biggest practical difference is insurance: Ozempic is often covered for diabetes patients, while Wegovy coverage for weight loss varies widely by plan
- Wegovy reaches a higher maximum dose (2.4 mg vs 2.0 mg), which may produce slightly more weight loss
- Ozempic is sometimes prescribed off-label for weight loss, but Wegovy is the on-label choice for that purpose
- The titration schedules differ — Wegovy has a 5-step escalation, Ozempic has a 3-4 step escalation
Which Should You Choose?
Choose Ozempic
Choose Ozempic if you have type 2 diabetes and want blood sugar control plus modest weight loss. It's more likely to be covered by insurance for diabetic patients.
Full Ozempic GuideChoose Wegovy
Choose Wegovy if your primary goal is weight loss and you have a BMI ≥30 (or ≥27 with weight-related conditions). It's the on-label choice for chronic weight management.
Full Wegovy Guide